165 related articles for article (PubMed ID: 19897333)
1. Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals.
Geraghty PJ; Matsumura JS; Conte MS
J Vasc Surg; 2009 Dec; 50(6):1459-61. PubMed ID: 19897333
[TBL] [Abstract][Full Text] [Related]
2. FDA perspective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.
Kumar A; Brooks SS; Cavanaugh K; Zuckerman B
J Vasc Surg; 2009 Dec; 50(6):1474-6. PubMed ID: 19897334
[TBL] [Abstract][Full Text] [Related]
3. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.
Conte MS; Geraghty PJ; Bradbury AW; Hevelone ND; Lipsitz SR; Moneta GL; Nehler MR; Powell RJ; Sidawy AN
J Vasc Surg; 2009 Dec; 50(6):1462-73.e1-3. PubMed ID: 19897335
[TBL] [Abstract][Full Text] [Related]
4. FDA marketing claims, and the practitioner.
Runner S
J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
[TBL] [Abstract][Full Text] [Related]
5. The "art" of medicine and the "smokescreen" of the randomized trial off-label use of vascular devices.
Ansel GM; Jaff MR
Catheter Cardiovasc Interv; 2008 Dec; 72(7):998-1002. PubMed ID: 19021289
[TBL] [Abstract][Full Text] [Related]
6. Medical devices; exemptions from premarket notification; class II devices; vascular tunnelers. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Mar; 65(43):11466-7. PubMed ID: 11010650
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
Rathi VK; Krumholz HM; Masoudi FA; Ross JS
JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
[TBL] [Abstract][Full Text] [Related]
8. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
[TBL] [Abstract][Full Text] [Related]
9. Food and Drug Administration regulation of in vitro diagnostic devices.
Mansfield E; O'Leary TJ; Gutman SI
J Mol Diagn; 2005 Feb; 7(1):2-7. PubMed ID: 15681468
[TBL] [Abstract][Full Text] [Related]
10. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
[TBL] [Abstract][Full Text] [Related]
11. Cochlear implants: overview of safety and effectiveness. The FDA evaluation.
Yin L; Segerson DA
Otolaryngol Clin North Am; 1986 May; 19(2):423-33. PubMed ID: 3520445
[TBL] [Abstract][Full Text] [Related]
12. Medical device recall authority--FDA. Final rule.
Fed Regist; 1996 Nov; 61(225):59004-22. PubMed ID: 10163116
[TBL] [Abstract][Full Text] [Related]
13. Prosthetic heart valves: Objective Performance Criteria versus randomized clinical trial.
Grunkemeier GL; Jin R; Starr A
Ann Thorac Surg; 2006 Sep; 82(3):776-80. PubMed ID: 16928482
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular, orthopedic, and physical medicine diagnostic devices; reclassification of cardiopulmonary bypass accessory equipment, goniometer device, and electrode cable devices. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Apr; 65(70):19317-9. PubMed ID: 11010630
[TBL] [Abstract][Full Text] [Related]
15. Obstetric and gynecology devices; effective date of requirement for premarket approval for glans sheath devices. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Jun; 67(115):40848-9. PubMed ID: 12068899
[TBL] [Abstract][Full Text] [Related]
16. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
[TBL] [Abstract][Full Text] [Related]
17. Medical device; exemption from premarket notification; class II devices; barium enema retention catheters and tips with or without a bag. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Dec; 65(237):76930-2. PubMed ID: 11503724
[TBL] [Abstract][Full Text] [Related]
18. Medical devices; effective date of requirement for premarket approval for three preamendment class III devices. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Apr; 65(72):19833-4. PubMed ID: 11010634
[TBL] [Abstract][Full Text] [Related]
19. Premarket clinical evaluation of novel cardiovascular devices: quality analysis of premarket clinical studies submitted to the Food and Drug Administration 2000-2007.
Kramer DB; Mallis E; Zuckerman BD; Zimmerman BA; Maisel WH
Am J Ther; 2010; 17(1):2-7. PubMed ID: 20038828
[TBL] [Abstract][Full Text] [Related]
20. Medical devices; exemptions from premarket notification; surgical lamps--FDA. Notice.
Fed Regist; 1998 Dec; 63(233):67075-6. PubMed ID: 10338882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
